| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Outline of Final Research Achievements |
Low SLC22A18 protein expression has been reported to be associated with a poor survival rate in several cancers. In this study, we investigated the expression and functional role of SLC22A18 in HepG2 hepatoblastoma cells. Western blotting confirmed the protein expression of SLC22A18 in HepG2 cells. The invasiveness of SLC22A18-knockdown HepG2 cells was increased, while proliferation and chemotaxis of SLC22A18-knockdown HepG2 cells were reduced. Quantitative whole proteomic analysis using SWATH technology demonstrates a significant change in the intracellular proteins involved in cell proliferation in the SLC22A18-knockdown HepG2 cells. These findings suggest that SLC22A18 plays a pivotal role in the regulation of hepatocarcinoma cancer cell growth characteristics, by altering the expression of cellular proteins.
|
